	US 12,257,268 B2
	Antitumor application of polysaccharide carbon nanogels
Chih-Ching Huang, Keelung (TW); Ju-Yi Mao, Kaohsiung (TW); and Chen-Yow Wang, Yunlin County (TW)
Assigned to NATIONAL TAIWAN OCEAN UNIVERSITY, Keelung (TW)
Filed by National Taiwan Ocean University, Keelung (TW)
Filed on Feb. 7, 2022, as Appl. No. 17/666,538.
Application 17/666,538 is a continuation in part of application No. 17/169,637, filed on Feb. 8, 2021, granted, now 11,672,819.
Prior Publication US 2022/0257638 A1, Aug. 18, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/734 (2006.01); A61K 9/06 (2006.01); A61K 47/02 (2006.01); B82Y 5/00 (2011.01); B82Y 30/00 (2011.01)

CPC A61K 31/734 (2013.01) [A61K 9/06 (2013.01); A61K 47/02 (2013.01); B82Y 5/00 (2013.01); B82Y 30/00 (2013.01)]

18 Claims

1. A pharmaceutical composition for treating tumor disease or neoplastic disorder comprising a nanogel and a pharmaceutically acceptable vehicle thereof, wherein the nanogel comprises a graphene-like nanosheet and a polysaccharide, and the graphene-like nanosheet comprises a carbonization product of at least a portion of the polysaccharide, and the graphene-like nanosheet is complexed with the polysaccharide to form a cross-linked supramolecular structure;

wherein the polysaccharide is a salt of alginic acid.